Navigate SLP clinic acquisitions with a broker who understands payer mix, clinician retention, and healthcare compliance in the lower middle market.
Find Speech Therapy Practice Deals Without a BrokerSpeech therapy practices selling between $1M–$5M in revenue require brokers with healthcare transaction experience. Key deal factors include SLP staff independence from the founder, diversified payer mix across insurance and Medicaid, and referral durability with schools and physicians. EBITDA multiples typically range from 3.5x to 6x depending on owner involvement, compliance history, and team depth.
Specializes in therapy and rehabilitation practice transactions, understands payer credentialing, HIPAA compliance, and clinical staffing dynamics unique to SLP practices.
Best for: Practices with $2M–$5M revenue seeking strategic buyers or PE-backed therapy platform acquirers.
Experienced with SBA 7(a) loan structures common in SLP acquisitions, helping buyers and sellers navigate lender requirements, goodwill allocation, and seller note structuring.
Best for: Smaller practices under $2M revenue where individual SLP buyers are financing with SBA loans.
Handles multi-industry deals but may lack depth in healthcare compliance or clinical staffing nuances; useful when healthcare specialists are unavailable in a specific region.
Best for: Sellers in rural or underserved markets with limited access to specialized healthcare brokers.
Skip the broker — find deals direct
DealFlow OS surfaces off-market Speech Therapy Practice targets with seller signals and outreach angles. No commission.
How many speech therapy or outpatient rehabilitation practices have you closed in the last three years?
Healthcare practice transactions differ significantly from general business sales; closed SLP deals demonstrate relevant payer mix and clinical staffing expertise.
How do you handle valuation when the owner performs a significant portion of billable clinical hours?
Owner-dependent revenue inflates perceived EBITDA; brokers must know how to normalize earnings and communicate transition risk to buyers accurately.
What is your process for marketing the practice while protecting patient confidentiality and HIPAA compliance?
Premature disclosure of a sale can disrupt staff and referral sources; proper NDAs and blind teasers are essential in healthcare transactions.
Do you have relationships with SBA lenders who are pre-approved to finance speech therapy practice acquisitions?
SBA lenders vary in comfort with healthcare goodwill; brokers with lender relationships accelerate deal timelines and improve buyer financing certainty.
Speech therapy practices typically sell at 3.5x–6x EBITDA. Higher multiples apply to practices with 3+ employed SLPs, diversified payer mix, and minimal owner clinical involvement.
Yes. Healthcare brokers understand payer credentialing, HIPAA-compliant marketing, and clinical staffing risk — factors that significantly affect valuation and buyer qualification in SLP transactions.
Yes. SBA 7(a) loans are commonly used, typically requiring 10–20% buyer equity. Sellers often carry a 5–10% subordinated note to satisfy lender requirements at closing.
Most SLP practice sales take 12–18 months from engagement to close, including preparation, marketing, buyer qualification, due diligence, and SBA financing approval timelines.
More Speech Therapy Practice Guides
Find Brokers in Other Industries
DealFlow OS surfaces off-market targets, scores seller motivation, and writes your outreach. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers